The Current Gap in GLP-1 Nutrition Guidance Traditional medical weight loss approaches often leave patients navigating nutrition alone after receiving their prescription
FDA-approved GLP-1 medications like tirzepatide (Mounjaro) work with your metabolism to slow digestion and reduce hunger while also helping to lower blood pressure, improve cholesterol levels, and reduce the risk of developing conditions like type 2 diabetes and heart disease
Before assuming the medication isn't working, there's a question worth asking first: is your genetic profile positioned to respond to a GLP-1 in the first place
Given these associations, its not surprising that numerous clinical trials are currently investigating the potential impact of semaglutide on these health conditions. This month the company that produces Wegovy, Novo Nordisk, announced the weight-loss jab can reduce the risk of major cardiovascular events, such as stroke or heart attack, by 20% in people who are overweight or living with obesity
Come for the Convenience, Stay for the Service
